Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

Missing some action, adrenaline rush, and thrill in your life? Are the good old, albeit mundane money investment avenues like mutual funds and fixed deposits not making the cut for you? Want to experience a heart-pounding, financial rollercoaster that will constantly keep you and your portfolio on tenterhooks? Well then, welcome to the world of initial public offers (IPOs), especially those brought to you by SMEs, or <keyword id="6375845" type="General" weightage="20" keywordseo="Small-and-Medium-Enterprises" source="Orion">small and medium enterprises</keyword>. Truth be told, <keyword id="3704207" type="General" weightage="100" keywordseo="SME-IPOs" source="Orion">SME IPOs</keyword> have been all over the bourses this year. So far, 2024 has seen 206 SMEs debuting on both BSE and NSE, out of which 146 listed in gains and 46 listed in losses. Odds seem good, right? In contrast, the year has only seen 63 IPOs from the elder brother i.e. mainboard, only 48 of which managed to post any listing gains. And getting an allotment has also been a major uncertainty, given the unusually high demand this year. <h2>So, what's an SME <keyword id="6354763" type="General" weightage="20" keywordseo="IPO" source="Orion">IPO</keyword>, you ask?</h2>Think of a mainboard company as Shah Rukh or Salman Khan—well-established, financially stable, strong legacy of profitability, and fairly well-known. On the other hand, SMEs are your Prateek Gandhi (Harshad Mehta, Scam 1992), Siddhant Chaturvedi (MC Sher, Gully Boy) or Avinash Tiwary (Majnu, Laila Majnu). While they are doing super well, they are yet to make it big like the Khans. They’re currently underdogs, lesser known, but who knows? They can be the next big thing in the future! And SME IPOs are getting a stellar reception. In 2023, 182 such IPOs had raised a substantial Rs 4,967 crore. In 2024, more than 200 companies have already raised over Rs 7,500 crore, and we have four months to go. This, with one quarter of the year still remaining. <div type="image" title="In 2024, India leads IPO activity in the Asia-Pacific region" height="900" width="1200" msid="113875643" hostid="261" caption="&amp;lt;p&amp;gt;In 2024, India leads IPO activity in the Asia-Pacific region&amp;lt;/p&amp;gt;"></div> But what does it take for a company to be classified as a small enterprise? The company has to have an annual turnover/income of up to Rs 50 crore, and for a medium enterprise to be called so, its annual income has to be up to Rs 250 crore. When such companies go public, in a bid to raise funds from investors and expand their operations, they launch an IPO, but not on the main exchange, but separately, on NSE’s Emerge and BSE’s SME platform. As of September 2024, <keyword id="4484133" type="General" weightage="20" keywordseo="NSE-Emerge" source="Orion">NSE Emerge</keyword> has 147 listed participants, while <keyword id="1885131" type="General" weightage="20" keywordseo="BSE-SME" source="Orion">BSE SME</keyword> has 155 market makers. Mounting an SME’s IPO is comparatively less stringent than their mainboard counterparts, as far as regulations are concerned since their DRHPs (draft <keyword id="12225712" type="General" weightage="20" keywordseo="Red-herring-prospectus" source="Orion">red herring prospectus</keyword>) are not filed with SEBI. So, wouldn’t a lenient treatment make them inherently riskier? Why are they so appealing, you ask? <a href="https://www.businessinsider.in/stock-market/news/a-company-with-8-employees-looking-to-raise-12-crore-ended-up-getting-applications-worth-over-4700-crore/articleshow/112824522.cms">Delhi firm with just 8 employees seeks ₹12 crore via IPO, gets ₹4,700 crore worth of investor applications!</a> Well, for one, some of them have delivered exceptional returns—we’re talking 100%, 200%. Consider this—Owais Metal and Mineral Processing, which launched its IPO in February this year, delivered a whopping listing gain of 201%. Another SME, Maxposure, whose IPO was out in January 2024, had earned its investors listing gains worth 317.40%! Apparently, higher risks also mean higher returns, and also super high investment. Most SME IPOs need a minimum investment of Rs 1,00,000 or more, as opposed to mainboard IPOs, where you can buy one lot of shares for anywhere between Rs 14,000-15,000. Even the minimum trading lot size for SME shares is about 10,000. In short, you’d have to potentially empty your pockets to invest in an SME IPO. And still, there’s no guarantee that the listing will fill your wallets. For all you know, your pockets before and after the IPO is listed might stay the same - EMPTY! There's also the question of whether or not these SMEs are able to maintain their listing day mojo, or do they just fizzle out thereafter? Data from Prime Database highlights more instances of the latter. As of August 2024, about 166 SME IPOs had made it to the exchanges. Around 72 of them, or close to 50%, could not sustain their momentum going ahead, and were trading below their listing day prices. Consider this. The post listing gains of Medicamen Organics, whose IPO came out in June 2024, earned its investors massive listing gains of over 300%, by listing at Rs 137.85, significantly higher than its price issue price, which was set between Rs 32-34. But as of October 1, 2024, the stock was trading at Rs 64.2. Talk about falls. Additionally, risks of pump-and-dump, and illiquidity, among others makes SME IPOs dangerous See, you're largely venturing into unknown, pitch-dark territories, without much light to guide you. For starters, SME IPOs face less scrutiny from market watchdog SEBI. This also means they are able to list quickly, just 3-4 months. On the other hand, mainboard IPOs can take upto a year before they are cleared for listing. Also, there is far less information and disclosures available about their financials, fundamentals and performance to investors for making an informed decision, as compared to mainboard stocks. Then there’s the issue of illiquidity. Once purchased, you might find it hard to sell off your SME stocks, since they are not traded as frequently in the market, which means lower liquidity. Trivesh D, COO, Tradejini explains that liquidity is a major concern for such stocks. “These stocks typically have a smaller free float, and are traded in lots, which can lead to volatility and sharp price swings. This means it can be challenging for investors to buy or sell shares without significantly impacting prices. Additionally, speculative trading practices, like 'pump-and-dump' schemes, can inflate stock prices, leaving retail investors vulnerable to sudden drops”. Recently, SME IPOs have gained notoriety for price manipulation via showing fictitious sales and revenue in their books of accounts, selling of promoter holdings at inflated prices, and being the facade for many infamous <keyword id="10663340" type="General" weightage="20" keywordseo="Pump-and-Dump" source="Orion">pump and dump</keyword> schemes. This is where select people create frenzy, or mass euphoria over a particular stock or company, causing its prices to soar, and then dumping them, or selling their shares at this massive price to make a killing! Infact, it's not just the promoters, but also the investment banks floating these IPOs. At present, SEBI is investigating around 6 investment banks which have allegedly charged SMEs a staggering 15% of funds raised via IPOs as fee, as opposed to the standard 1-3%. In March 2024, SEBI chairperson Madhabi Puri Buch had also highlighted witnessing signs of manipulation in the SME space. “We do see signs of manipulation in the SME segment. We are able to see certain patterns.” Buch had observed back then. Adds Kresha Gupta, Founder &amp; Director, StepTrade Share Services, “Investing in SME IPO comes with significant risks, despite their impressive returns in recent years. Limited participation from institutional investors and public in some SME IPOs also mean that those companies may lack the support and stability that comes with larger-scale investments” “Additionally, many SMEs may not have strong fundamentals to justify their valuations. High P/E ratios can be misleading, and while some IPOs have delivered impressive returns, they often come with significant volatility, continues D of Tradejini. <h2>So, should I stay away? </h2>Yes, and No. Yes, if you don't want to do your homework of researching the company thoroughly beforehand. Anand K. Rathi, Co-Founder of MIRA Money suggests asking a couple of questions before investing your hard earned money: <ul><li>What is the company's financial performance over the past 3-4 years?</li><li>What is the company's governance structure?</li><li>Is the financial success driven by the IPO, or is it a result of consistent performance?</li><li>Does the company have what it takes to scale its operations to the next level?</li><li>Are the company’s promoters trustworthy, capable and experienced?</li><li>What is the level of participation by large, institutional investors?</li></ul> But staying away completely? Not necessary. Gupta adds that retail investors, in particular, should avoid viewing SME IPOs as quick money-makers based on their short-term performance, as this can certainly lead to poor investment decisions. “To mitigate risks, investors should always focus on long-term fundamentals rather than just short-term price movements. Key indicators include the participation of institutional investors like DIIs and FIIs. This often signals confidence in the stock”, she continues. A red flag you should look out for is if a company is only offering OFS, or Offer for Sale. This can indicate early investors looking to exit, potentially signaling weaker future growth. That's why it is better to look for companies which are raising capital for expansion purposes. This is a sign of healthy business growth prospects and improving fundamentals. In conclusion, backing the underdog, or SMEs, is not a bad proposition, but not without its risks. Investing in SME IPOs is like riding a unicorn—but you don't know whether you're riding it to rags or riches! So, take your pick.

Why investing in SME IPOs should not be on top of your adventure to-do list!

<div type="image" title="In 2024, India has seen around $12.2 billion worth of IPOs, including mainboard and SMEs" msid="113878163" hostid="261" sizebytes="45300" caption="&amp;lt;p&amp;gt;In 2024, India has seen around $12.2 billion worth of IPOs, including mainboard and SMEs&amp;lt;/p&amp;gt;"></div> Missing some action, adrenaline rush, and thrill in your life? Are the good old, albeit mundane money investment avenues like mutual funds and fixed deposits not making the cut for you? Want to experience a heart-pounding, financial rollercoaster that will constantly keep you and your portfolio on tenterhooks? Well then, welcome to the world of initial public offers (IPOs), especially those brought to you by SMEs, or <keyword id="6375845" type="General" weightage="20" keywordseo="Small-and-Medium-Enterprises" source="Orion">small and medium enterprises</keyword>. Truth be told, <keyword id="19938687" type="General" weightage="20" keywordseo="sme" source="keywords">SME</keyword> IPOs have been all over the bourses this year. So far, 2024 has seen 206 SMEs debuting on both BSE and NSE, out of which 146 listed in gains and 46 listed in losses. Odds seem good, right? In contrast, the year has only seen 63 IPOs from the elder brother i.e. mainboard, only 48 of which managed to post any listing gains. And getting an allotment has also been a major uncertainty, given the unusually high demand this year. <h2 style="margin-bottom: 0.7em; line-height: 1.3; color: rgb(0, 0, 0); font-size: 24px; background: 0px 0px; text-rendering: optimizelegibility;">So, what's an <keyword id="5559702" type="General" weightage="100" keywordseo="SME-IPO" source="Orion">SME IPO</keyword>, you ask?</h2>Think of a mainboard company as Shah Rukh or Salman Khan—well-established, financially stable, strong legacy of profitability, and fairly well-known. On the other hand, SMEs are your Prateek Gandhi (Harshad Mehta, Scam 1992), Siddhant Chaturvedi (MC Sher, Gully Boy) or Avinash Tiwary (Majnu, Laila Majnu). While they are doing super well, they are yet to make it big like the Khans. They’re currently underdogs, lesser known, but who knows? They can be the next big thing in the future! And SME IPOs are getting a stellar reception. In 2023, 182 such IPOs had raised a substantial Rs 4,967 crore. In 2024, more than 200 companies have already raised over Rs 7,500 crore, and we have four months to go. This, with one quarter of the year still remaining. <div type="image" title="In 2024, India leads IPO activity in the Asia-Pacific region" height="900" width="1200" msid="113875643" hostid="261" caption="&amp;lt;p&amp;gt;In 2024, India leads IPO activity in the Asia-Pacific region&amp;lt;/p&amp;gt;"></div> But what does it take for a company to be classified as a small enterprise? The company has to have an annual turnover/income of up to Rs 50 crore, and for a medium enterprise to be called so, its annual income has to be up to Rs 250 crore. When such companies go public, in a bid to raise funds from investors and expand their operations, they launch an <keyword id="19898327" type="General" weightage="20" keywordseo="ipo" source="keywords">IPO</keyword>, but not on the main exchange, but separately, on NSE’s Emerge and BSE’s SME platform. As of September 2024, <keyword id="4484133" type="General" weightage="20" keywordseo="NSE-Emerge" source="Orion">NSE Emerge</keyword> has 147 listed participants, while <keyword id="1885131" type="General" weightage="20" keywordseo="BSE-SME" source="Orion">BSE SME</keyword> has 155 market makers. Mounting an SME’s IPO is comparatively less stringent than their mainboard counterparts, as far as regulations are concerned since their DRHPs (draft red herring prospectus) are not filed with SEBI. So, wouldn’t a lenient treatment make them inherently riskier? Why are they so appealing, you ask? <a href="https://www.businessinsider.in/stock-market/news/a-company-with-8-employees-looking-to-raise-12-crore-ended-up-getting-applications-worth-over-4700-crore/articleshow/112824522.cms">Delhi firm with just 8 employees seeks ₹12 crore via IPO, gets ₹4,700 crore worth of investor applications!</a> Well, for one, some of them have delivered exceptional returns—we’re talking 100%, 200%. Consider this—Owais Metal and Mineral Processing, which launched its IPO in February this year, delivered a whopping listing gain of 201%. Another SME, Maxposure, whose IPO was out in January 2024, had earned its investors listing gains worth 317.40%! Apparently, higher risks also mean higher returns, and also super high investment. Most SME IPOs need a minimum investment of Rs 1,00,000 or more, as opposed to mainboard IPOs, where you can buy one lot of shares for anywhere between Rs 14,000-15,000. Even the minimum trading lot size for SME shares is about 10,000. In short, you’d have to potentially empty your pockets to invest in an SME IPO. And still, there’s no guarantee that the listing will fill your wallets. For all you know, your pockets before and after the IPO is listed might stay the same - EMPTY! There's also the question of whether or not these SMEs are able to maintain their listing day mojo, or do they just fizzle out thereafter? Data from Prime Database highlights more instances of the latter. As of August 2024, about 166 SME IPOs had made it to the exchanges. Around 72 of them, or close to 50%, could not sustain their momentum going ahead, and were trading below their listing day prices. Consider this. The post listing gains of Medicamen Organics, whose IPO came out in June 2024, earned its investors massive listing gains of over 300%, by listing at Rs 137.85, significantly higher than its price issue price, which was set between Rs 32-34. But as of October 1, 2024, the stock was trading at Rs 64.2. Talk about falls. Additionally, risks of pump-and-dump, and illiquidity, among others makes SME IPOs dangerous See, you're largely venturing into unknown, pitch-dark territories, without much light to guide you. For starters, SME IPOs face less scrutiny from market watchdog SEBI. This also means they are able to list quickly, just 3-4 months. On the other hand, mainboard IPOs can take upto a year before they are cleared for listing. Also, there is far less information and disclosures available about their financials, fundamentals and performance to investors for making an informed decision, as compared to mainboard stocks. Then there’s the issue of illiquidity. Once purchased, you might find it hard to sell off your SME stocks, since they are not traded as frequently in the market, which means lower liquidity. Trivesh D, COO, Tradejini explains that liquidity is a major concern for such stocks. “These stocks typically have a smaller free float, and are traded in lots, which can lead to volatility and sharp price swings. This means it can be challenging for investors to buy or sell shares without significantly impacting prices. Additionally, speculative trading practices, like 'pump-and-dump' schemes, can inflate stock prices, leaving retail investors vulnerable to sudden drops”. Recently, SME IPOs have gained notoriety for price manipulation via showing fictitious sales and revenue in their books of accounts, selling of promoter holdings at inflated prices, and being the facade for many infamous pump and dump schemes. This is where select people create frenzy, or mass euphoria over a particular stock or company, causing its prices to soar, and then dumping them, or selling their shares at this massive price to make a killing! Infact, it's not just the promoters, but also the investment banks floating these IPOs. At present, SEBI is investigating around 6 investment banks which have allegedly charged SMEs a staggering 15% of funds raised via IPOs as fee, as opposed to the standard 1-3%. In March 2024, SEBI chairperson Madhabi Puri Buch had also highlighted witnessing signs of manipulation in the SME space. “We do see signs of manipulation in the SME segment. We are able to see certain patterns.” Buch had observed back then. Adds Kresha Gupta, Founder &amp; Director, StepTrade Share Services, “Investing in SME IPO comes with significant risks, despite their impressive returns in recent years. Limited participation from institutional investors and public in some SME IPOs also mean that those companies may lack the support and stability that comes with larger-scale investments” “Additionally, many SMEs may not have strong fundamentals to justify their valuations. High P/E ratios can be misleading, and while some IPOs have delivered impressive returns, they often come with significant volatility, continues D of Tradejini. <h2 style="box-sizing: border-box; border: 0px; outline: 0px; padding: 0px; margin: 0px 0px 0.7em; font-family: &quot;Open Sans&quot;, sans-serif; font-weight: 700; line-height: 1.3; color: rgb(0, 0, 0); font-size: 24px; list-style: none; background: 0px 0px; text-rendering: optimizelegibility; text-transform: none; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">So, should I stay away?</h2>Yes, and No. Yes, if you don't want to do your homework of researching the company thoroughly beforehand. Anand K. Rathi, Co-Founder of MIRA Money suggests asking a couple of questions before investing your hard earned money: <ul><li>What is the company's financial performance over the past 3-4 years?</li><li>What is the company's governance structure?</li><li>Is the financial success driven by the IPO, or is it a result of consistent performance?</li><li>Does the company have what it takes to scale its operations to the next level?</li><li>Are the company’s promoters trustworthy, capable and experienced?</li><li>What is the level of participation by large, institutional investors?</li></ul> But staying away completely? Not necessary. Gupta adds that retail investors, in particular, should avoid viewing SME IPOs as quick money-makers based on their short-term performance, as this can certainly lead to poor investment decisions. “To mitigate risks, investors should always focus on long-term fundamentals rather than just short-term price movements. Key indicators include the participation of institutional investors like DIIs and FIIs. This often signals confidence in the stock”, she continues. A red flag you should look out for is if a company is only offering OFS, or Offer for Sale. This can indicate early investors looking to exit, potentially signaling weaker future growth. That's why it is better to look for companies which are raising capital for expansion purposes. This is a sign of healthy business growth prospects and improving fundamentals. In conclusion, backing the underdog, or SMEs, is not a bad proposition, but not without its risks. Investing in SME IPOs is like riding a unicorn—but you don't know whether you're riding it to rags or riches! So, take your pick.

SIMPLY PUT: Why investing in SME IPOs should not be on top of your adventure to-do list!

<ul><li>Shares of <keyword id="6926409" type="General" weightage="20" keywordseo="ami-organics" source="Orion">Ami Organics</keyword> listed on the stock exchanges at ₹910 per share, which is 50% higher than the issue price.</li><li>The company’s initial public offer (IPO) was oversubscribed by over 64 times.</li><li>It intends to use a bulk of the proceeds of the IPO towards repaying its debts.</li></ul>Shares of Ami Organics, one of the two new companies to get listed on the Indian stock exchanges, debuted at ₹910 per share, which is 50% above its issue price of ₹610. The specialty chemical maker <a href="https://www.businessinsider.in/stock-market/news/ami-organics-wants-to-become-debt-free-post-the-ipo/articleshow/85781458.cms">floated</a> its ₹570 crore initial public offer (IPO) earlier this month. The IPO was oversubscribed by 64 times, with non-institutional investors leading the fray. With the IPO proceeds, the Gujarat-based specialty chemicals company will pay off its debt worth ₹140 crore and become debt free, Naresh Patel, chief managing director of Ami Organics, said in an interview with Business Insider. Over the last few months, several specialty chemicals companies debuted on the stock exchanges, receiving a mixed response. While Clean Science and Technology and Tatva Chintan Pharma received a good response, the market was not excited about Chemplast Sanmar and Anupam Rasayan. As of 2:15 p.m., <a href="https://www.businessinsider.in/stock-market/news/ami-organics-wants-to-become-debt-free-post-the-ipo/articleshow/85781458.cms">Ami Organics’ shares</a> were trading at ₹930 per share, which is up by over 52%. The grey market premium for Ami Organics’ shares was hovering around ₹150, which translates to approximately 25% of the issue price of ₹610. It is worth noting that the grey market premium is not an official measure of market premium. Ami Organics is a research and development driven manufacturer of speciality chemicals. The company manufactures different types of advanced pharmaceutical intermediates and active pharmaceutical ingredients (API) for new chemical entities, and material for agrochemicals and fine chemicals. The company is also working on cutting down raw material dependence on supplying countries like China. It imported 19.39% of total raw material purchase from China in FY21 as compared to 21.85% in FY20 and 22.11% in FY19. “We have been strategically working on cutting down raw material dependence on one single country like China. I hope we can pull it down below two digits in the coming years,” said Patel. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/sansera-engineering-ipo-is-opening-from-today-and-closes-on-september-16/articleshow/86189006.cms">INTERVIEW: An auto parts maker for Maruti, Bajaj and Honda is betting that Indian car makers will take a leaf out of Tesla’s playbook</a> <a href="https://www.businessinsider.in/tech/gadgets/news/xiaomis-first-smart-glasses-can-take-calls-capture-photos-translate-text-and-more/articleshow/86189049.cms">Xiaomi’s first smart glasses can take calls, capture photos, translate text and more</a> <a href="https://www.businessinsider.in/tech/news/facebook-admits-it-messed-up-again/articleshow/86171788.cms">Facebook admits it messed up again</a>

Ami Organics dazzles on its stock market debut, lists at a premium of 50%

<ul><li>Speciality chemicals firm Ami Organics was fully subscribed on the first day of bidding on September 1.</li><li>So far, in the last two days of issue, it has received good response from retail investors followed by institutional investors.</li><li>The grey market premium is indicating a strong premium of over ₹150.</li></ul>Speciality chemical company Ami Organics launched its initial public offering (IPO) on September 1. Today, September 3, is the last day to subscribe to its IPO. In the last few months, three speciality chemicals companies -- Clean Science and Technology, Tatva Chintan Pharma Chem and Chemplast Sanmar -- had hit the market. Except for Chemplast Sanmar, the other two made a strong listing on the exchanges. Enthuthiasm around <keyword id="11958218" type="General" weightage="20" keywordseo="ami-organics-ipo" source="Orion">Ami Organics IPO</keyword> is huge given the IPO was fully subscribed in the first few hours on the first day of bidding. As of September 2, the IPO has been oversubscribed by 3.90 times. The IPO has received bids for 2.55 crore equity shares against the IPO size of 65.36 lakh equity shares. With the IPO proceeds, the Gujarat-based specialty chemicals company will pay off its debt worth ₹140 crore and become debt-free, Naresh Patel, chief managing director of Ami Organics, said in an interview with Business Insider. The grey market indicates a premium of over ₹150 on the issue price. It has set a price band of ₹603 to ₹610. Here are some important dates related to the IPO: <table style="border-width: initial; border-style: none;" class="redcator-table-advance"></colgroup><tbody><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Issue details </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;"> </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Price band </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹603 to ₹610 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO open date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 1 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO close date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 3 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Allotment date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 8 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Initiation of refunds </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 9 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Credit of shares to demat account </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 13 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO listing date </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">September 14 </td></tr><tr><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Minimum lot </td><td style="border-left:solid #000000 0.75pt;border-right:solid #000000 0.75pt;border-bottom:solid #000000 0.75pt;border-top:solid #000000 0.75pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">24 </td></tr></tbody><tbody></tbody></table> The company is looking to raise ₹200 crore through fresh issue of shares and 60.59 lakh shares through offer for sale by promoters. Overall, the company is aiming to raise ₹570 crore on the upper price band of ₹603 to ₹610 per share. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/startups/news/six-month-old-investment-advisory-startup-dezerv-raises-7-million/articleshow/85865111.cms">Six-month-old investment advisory startup Dezerv raises $7 million</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/news/apple-hit-with-antitrust-case-in-india-over-in-app-payment-concerns/articleshow/85862008.cms">Apple hit with antitrust case in India alleging its 30% commission is unfair for customers and app developers</a>

Last day to subscribe to Ami Organics IPO, issue oversubscribed by almost four times

<ul><li>Ami Organics is likely to announce its share allotment status on September 8.</li><li>Speciality chemical company Ami Organics received a strong response from investors during all three days of the IPO bidding process.</li><li>The IPO of the company received bids for 42.22 crore as against the IPO size of 65.36 lakh shares.</li></ul>Ami Organics is likely to announce the allotment status of its initial public offering (IPO) on September 8. The IPO was open for subscription from September 1 to September 3 with a price band of ₹603-610. The company is looking to raise ₹200 crore through fresh issue of shares and 60.59 lakh shares through offer for sale by promoters. Ami Organics’ IPO has received an amazing response from investors, especially non institutional investors. The portion reserved for qualified institutional investors was subscribed 86.02 times, non institutional investors subscribed 155.44 times and that for retail investors was subscribed 13.42 times. Ami Organics is a research and development driven manufacturer of speciality chemicals. The company manufactures different types of advanced pharmaceutical intermediates and active pharmaceutical ingredients (API) for new chemical entities, and material for agrochemicals and fine chemicals. With the IPO proceeds, the Gujarat-based speciality chemicals company will pay off its debt worth ₹140 crore and become debt free, Naresh Patel, chief managing director of Ami Organics, said in an interview with Business Insider. Here is how to <keyword id="12039981" type="General" weightage="20" keywordseo="ami-organics-ipo-allotment" source="Orion">Ami Organics IPO allotment</keyword> status on stock exchange website: <ul><li>Go to the <a href="https://www.bseindia.com/investors/appli_check.aspx">BSE website</a> or NSE website<a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp"> here</a>.</li><li>On BSE, Select 'Equity' and then from the dropdown, select ‘Ami Organics ’.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li><li>Please note the details will only be available once the shares are allotted.</li></ul>You can also visit the registrar website (Link Intime India) to check your application status. <ul><li>Visit the registrar's website <a href="https://linkintime.co.in/MIPO/Ipoallotment.html">here</a>.</li><li>Click on 'Select company' and click on 'Ami Organics‘.</li><li>Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.</li><li>Enter the captcha and click ’submit’.</li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/news/covid-19-delhi-reports-no-new-death-in-last-six-days/articleshow/85978889.cms">COVID-19: Delhi reports no new death in last six days</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/real-estate-company-stocks-become-multibaggers-while-analysts-see-further-strong-upside/articleshow/85976693.cms">Sobha, Mahindra Lifespace become multibaggers in 2021 as analysts see strong upside in realty space</a>

Details on how to check Ami Organics IPO allotment status, listing date and more

<ul><li>Analysts believe Vijaya Diagnostics's tepid subscription, higher valuation and price band may go against the public issue.</li><li>For <keyword id="11958218" type="General" weightage="20" keywordseo="ami-organics-ipo" source="Orion">Ami Organics IPO</keyword> analysts suggest short-term investors to book profit on listing day if they receive the allotment.</li><li>Check out the latest market news and updates on Business Insider.</li></ul><keyword id="2171617" type="General" weightage="20" keywordseo="vijaya-diagnostic-centre" source="Orion">Vijaya Diagnostic Centre</keyword> and <keyword id="6926409" type="General" weightage="20" keywordseo="ami-organics" source="Orion">Ami Organics</keyword> are set to be listed on exchanges tomorrow (September 14). However, the fate of the two IPOs may be different, if the grey market premium is considered to be an indicator. Grey Market is an unofficial market where individuals buy/sell IPO shares or applications before they are officially launched for trading on the stock exchanges. The IPO of companies was open to subscribe from September 1 to September 3. Ami Organics IPO may see a strong listing gains tomorrow The speciality chemical company is indicating a strong premium of ₹156 in the grey market ahead of its listing, also reflecting its robust subscription numbers. The IPO received bids for 42.22 crore as against the IPO size of 65.36 lakh shares on the last day of bidding. In the last few months, another specialty chemical company Clean Science and Technology and Tatva Chintan Pharma Chem made a strong listing on the exchanges. “We suggest short-term investors to book profit on listing day if they receive the allotment,” said Yash Gupta, equity research analyst at Angel Broking as he believes valuation is expensive. Ami Organics is all set to open around ₹570 crore initial public offering (IPO) for investors, indicating a premium of ₹156 a share in the grey market . With the IPO proceeds, the Gujarat-based specialty chemicals company will pay off its debt worth ₹140 crore and become debt free, Naresh Patel, chief managing director of Ami Organics, <a href="https://www.businessinsider.in/stock-market/news/ami-organics-wants-to-become-debt-free-post-the-ipo/articleshow/85781458.cms">said in an interview with Business Insider</a>. [hyperlink] Vijay Diagnostic Centre IPO might open weak on exchanges The chain of medical testing, Vijaya Diagnostic is trading at a discount in the grey market. Shares were available at a discount of around ₹12 a piece, to the issue price of ₹522, in the grey market. Analysts believe Vijaya's tepid subscription, higher valuation and price band may go against the public issue. “We are not expecting any big listing gain from <keyword id="11952026" type="General" weightage="20" keywordseo="vijaya-diagnostic-centre-ipo" source="Orion">Vijaya Diagnostic Centre IPO</keyword> as we believe that all the short term positives have been priced in the IPO price i.e ₹531,'' said Gupta from Angel Broking. The IPO received bids for 11.36 crore shares against the 2.50 crore shares on offer. However, analysts at Ventura Capital recommend subscribing to the IPO for long-term investing with a price objective of ₹672, representing an upside of 27% over the next 24 months attributing the company’s strong cash balance for future growth. The firm has ₹250 crore cash on its books, Sunil Chandra Kondapally, executive director at Vijaya Diagnostic, <a href="https://www.businessinsider.in/stock-market/news/ipo-bound-vijaya-diagnostics-is-planning-more-acquisitions-in-east-india/articleshow/85755911.cms">told Business Insider</a>. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/careers/news/tcs-wipro-and-apple-prepare-to-bring-people-back-to-work-from-office/articleshow/86160193.cms">As TCS, Wipro and Apple prepare to bring people back to work, there are many lessons from the last 18 months to consider</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/retail/news/radhakishan-damani-added-4-4-billion-to-his-net-worth-and-is-now-among-worlds-100-richest-people/slidelist/86160861.cms">Billionaire investor and DMart founder Radhakishan Damani is now among world’s 100 richest people</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/corporates/news/jet-airways-to-soon-start-its-domestic-flights-soon-after-march-2022/articleshow/86159868.cms">Jet Airways may start domestic flights after March 2022</a>

Grey market premium shows Ami Organics may shine on listing while Vijaya Diagnostic may stutter

<ul><li>Ami Organics recorded 83% returns in two trading sessions crossing the ₹1,000-mark on the second day of listing.</li><li>The market capitalisation of the company stood at ₹4,086 crore as on September 15.</li><li>Most analysts are suggesting to hold the stock for a long term considering the company’s strong hold in API and R&amp;D segment.</li></ul>After a series of lull listings, speciality chemical company Ami Organics’ initial public offering (IPO) not only made a blockbuster debut on exchanges, but continued with another 20% gain on the second day of listing. Altogether, the company delivered 83% returns in two trading sessions, meaning investors who held onto the stock till September 15 have made ₹12,288 profit in just two days. Shares of the Gujarat-based company, which debuted at ₹910 per share -- 50% above its issue price of ₹610 -- crossed the ₹1000-mark on the second day of listing. The market capitalisation of the company stood at ₹4,086 crore as on September 15. Most analysts had expected a strong debut for the initial public offering (IPO) betting on the growth prospects in the speciality chemical industry. Recently listed specialty chemical IPOs -- Clean Science and Technology and Tatva Chintan Pharma received a good response while Chemplast Sanmar got a dull one. On September 15, shares of Ami Organics were 20% higher at ₹1,122 per share. So, should investors hold onto the stocks or sell and book profits? Most analysts are suggesting to stay for a long term in the stock. Analysts at Motilal Oswal Securities <a href="https://www.business-standard.com/article/markets/ami-organics-surges-20-after-strong-debut-up-84-against-issue-price-121091500326_1.html">reportedly </a>said that, “We like Ami Organics given its wide product portfolio in pharma intermediates (PIs), diversification efforts into other specialty chemical space, strong clients’ relation across geographies and robust financials. It is well placed to tap opportunity in the fast growing specialty chemical market by leveraging its strong R&amp;D and expanding product portfolio.” Prashanth Tapse, vice president of research at Mehta Equities <a href="https://www.moneycontrol.com/news/business/markets/ami-organics-share-crosses-rs-1000-mark-spikes-84-amid-strong-buying-demand-in-2-days-7469031.html">reportedly</a> advised investors to hold on to the stock considering long term play. “Being in [a] high-growth high-margin therapeutic segment and promising outlook in light of the “China Plus One” strategy, Ami Organics is well placed to tap the sectoral growth with low competition and high entry barriers due to complex business nature,” said Tapse. China Plus One is the business strategy to avoid investing only in China and diversify business into other countries. Gaurav Garg, head of research at CapitalVia Global Research also reportedly advised to hold the stock for a long term. "The company has been consistently growing revenue from operations and net profit after tax from FY19 to FY21 and around 50% of revenue comes from exports," he reasoned. The strong traction in the pharma active pharmaceuticals ingredients (API) business and focus on research &amp; development (R&amp;D) and launching on new molecules will drive Ami Organics’ growth going forward, said Arijit Malakar, head of research (Retail) at Ashika Stock Broking. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/telecom/news/telecom-relief-package-airtel-vodafone-idea-get-four-year-moratorium-on-agr-dues/articleshow/86227218.cms">Indian government dials M for moratorium – Airtel, Vodafone Idea get a four-year relief on AGR dues</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/sensex-scales-to-another-record-high-led-by-energy-it-stock-bharti-airtel-crosses-4-trillion-mcap/slidelist/86226222.cms">Sensex scales to another record high led by energy, IT stocks; Bharti Airtel crosses 4 trillion market cap</a>

Investors who had put money in this IPO made over ₹12,000 profit on every lot in 2 days

<ul><li>Speciality chemicals company Ami Organics to open its IPO on September 1 and will close on September 3.</li><li>The company is looking to raise around ₹570 crore through the public listing.</li><li>The company is looking at paying off ₹140 crore debt from the IPO proceeds and become debt free.</li></ul>Speciality chemicals firm Ami Organics is all set to open its around ₹570 crore initial public offering (IPO) for investors this week. With the IPO proceeds, the Gujarat-based specialty chemicals company will pay off its debt worth ₹140 crore and become debt free, Naresh Patel, chief managing director of Ami Organics, said in an interview with Business Insider. The company is looking to raise ₹200 crore through fresh issue of shares and 60.59 lakh shares through offer for sale by promoters. Overall, the company is aiming to raise ₹570 crore on the upper price band of ₹603 to ₹610 per share. In the last few months, three specialty chemicals companies -- Clean Science and Technology, Tatva Chintan Pharma Chem and Chemplast Sanmar hit the market. Except for Chemplast Sanmar, the other two made a strong listing on the exchanges. Ami Organics is a research and development driven manufacturer of speciality chemicals. The company manufactures different types of advanced pharmaceutical intermediates and active pharmaceutical ingredients (API) for new chemical entities, and material for agrochemicals and fine chemicals. The company is also working on cutting down raw material dependence on supplying countries like China. It imported 19.39% of total raw material purchase from China in FY21 as compared to 21.85% in FY20 and 22.11% in FY19. “We have been strategically working on cutting down raw material dependence on one single country like China. I hope we can pull it down below two digits in the coming years,” said Patel. <div type="image" title="vijaya revenue" height="900" width="1200" msid="85786232" hostid="261"></div> The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e., anti-retroviral, anti-inflammatory, antipsychotic, anti-cancer, anti-Parkinson’s, anti-depressant, and anticoagulants. The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar and Jhagadia, with an aggregate installed capacity of 6,060 million tonnes per annum (MTPA). SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/sports/news/sumit-antil-clinches-indias-second-gold-in-paralympics-with-a-world-record-in-javelin-throw/articleshow/85766060.cms">Sumit Antil clinches India's second gold in Paralympics with a world record in javelin throw</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/telecom/news/airtel-founder-sunil-mittal-wants-to-increase-mobile-tariffs-by-at-least-33-in-2021/articleshow/85763847.cms">Airtel founder Sunil Mittal says your mobile bills need to increase significantly</a>

Ami Organics wants to become debt-free post the IPO, to cut dependence on China in the coming years

<ul><li>The basis of allotment for the ₹600 crore IPO of Laxmi Organics will be announced today on March 22.</li><li><keyword id="10930883" type="COMPANY" weightage="20" keywordseo="laxmi-organic">Laxmi Organic</keyword> is one of the largest manufacturers of ethyl acetate in India with a market share of 30%.</li><li>Here is how to check Laxmi Organic’s IPO allotment status on the registrar website and stock exchanges. </li></ul>The speciality chemicals manufacturer Laxmi Organic is the talk of the town with its ₹600 crore initial public offering (IPO) seeing subscription 106.81 times the offer value — most of which was driven by institutional investors. The allotment of shares is being finalised today, on March 22, which is likely to be followed by the company’s listing on March 25. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Laxmi Organic IPO </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Qualified Institutional Buyer </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Non-institutional Investor </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Retail Individual Investor </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Total </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">No. of times issue subscribed </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">175.43 times </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">217.62 times </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">20.10 times </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">106.81 times </td></tr></tbody></table> The rally behind Laxmi Organic’s IPO stems from its dominance in the market. Founded in 1989, it has over three decades of experience in large scale manufacturing of chemicals. And, it has a market share of 30% in the Indian ethyl acetate market. For those unfamiliar with the world of chemicals, ethyl acetate is colourless liquid commonly used in glues, nail polish removers, and in the decaffeination process of tea and coffee. It's also the only player in the country to make diketene derivatives. This is used in the making of paper, pharmaceuticals — which are currently hot due to demand for vaccines and the impetus by the Indian government on the healthcare sector — insecticides and dyes. Laxmi Organic’s IPO comprises fresh issuance of shares of up to ₹300 crore and an offer for sale (OFS) of up to ₹300 crore by the promoter group, Yellowstone Trust. The OFS is likely to further increase the chemical manufacturing major’s market share in India. Before opening the IPO to the market, the company pulled in ₹180 crore from anchor investors. The money will go towards Laxmi Organic’s working capital requirements and upgradation of existing units. Moreover, the company also plans on using the new capital to set up a manufacturing facility for fluoro speciality chemicals. However, after this stellar response that <keyword id="10895115" type="UNKNOWN" weightage="20" keywordseo="Laxmi-Organic-IPO">Laxmi Organic IPO</keyword> has garnered, one thing is certain — not all investors will get the same amount of shares that they had subscribed for. Here is <keyword id="10970094" type="UNKNOWN" weightage="20" keywordseo="how-to-check-laxmi-organic-ipo-allotment">how to check Laxmi Organic IPO allotment</keyword> status: If you subscribed to the Laxmi Organic IPO, you could check your allotment status by following these simple steps. To check on the stock-exchange website: <ul><li>To check <keyword id="10970092" type="UNKNOWN" weightage="20" keywordseo="laxmi-organic-IPO-allotment-status">Laxmi Organic IPO allotment status</keyword>, go to the<a href="https://www.bseindia.com/investors/appli_check.aspx"> BSE website</a> or <a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp">NSE website</a> here.</li><li>On BSE, Select 'Equity' and then from the dropdown, select 'Laxmi Organic'.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'. </li></ul>Please note the details will only be available once the shares are allotted. You can also visit the registrar website (Link Intime India) to check your application status. <ul><li>Visit the registrar's website <a href="https://linkintime.co.in/MIPO/Ipoallotment.html">here</a>.</li><li>Click on 'Select company' and click on 'Laxmi Organic'. It will only appear post allotment on March 22.</li><li>Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.</li><li>Enter the captcha and click 'submit'.</li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO: <a href="https://www.businessinsider.in/science/space/news/an-asteroid-twice-as-big-as-the-statue-of-unity-is-set-to-zoom-past-earth-tonight-flying-at-100000-kmph/articleshow/81610030.cms">The biggest asteroid of 2021 is going to zoom past Earth tonight flying as fast as 100,000 kmph</a> <a href="https://www.businessinsider.in/business/corporates/news/accenture-announces-one-time-bonus-for-all-employees-as-the-tech-giant-sees-robust-revenue-growth/articleshow/81572548.cms">Accenture announces one-time bonus for all employees as the tech giant sees robust revenue growth</a> <a href="https://www.businessinsider.in/science/space/news/finnish-photographer-jp-metsavainio-took-over-a-decade-and-1000-hours-of-photography-to-create-this-picture-of-the-milky-way-and-20-million-stars/slidelist/81563516.cms">It took over a decade and 1,000 hours of photography to create this picture of the Milky Way</a>

You Searched For "ami organics ipo listing price" and got 10 results

Why investing in SME IPOs should not be on top of your adventure to-do list!

BI India Bureau

SIMPLY PUT: Why investing in SME IPOs should not be on top of your adventure to-do list!

Ira Alok Puranik

Ami Organics dazzles on its stock market debut, lists at a premium of 50%

Rounak Jain

Last day to subscribe to Ami Organics IPO, issue oversubscribed by almost four times

Bhakti Makwana

Details on how to check Ami Organics IPO allotment status, listing date and more

Bhakti Makwana

Grey market premium shows Ami Organics may shine on listing while Vijaya Diagnostic may stutter

Bhakti Makwana

Investors who had put money in this IPO made over ₹12,000 profit on every lot in 2 days

Bhakti Makwana

Ami Organics wants to become debt-free post the IPO, to cut dependence on China in the coming years

Bhakti Makwana

Laxmi Organic IPO allotment live – how to check allotment, listing date and more

Prabhjote Gill

Vijaya Diagnostics, Ami Organics, Arohan Financial Services and more — Here is a list of upcoming IPOs

Bhakti Makwana

Popular Keywords

Buying Guides